Hong Kong · Delayed Price · Currency is HKD Vigonvita Life Sciences Company Description
Vigonvita Life Sciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas.
Its products include LV232, a first-in-class dual-target 5-HTT/5-HT modulators, which is in Phase II of clinical trial for the treatment of depressive disorder; and TPN171, a type-5 phosphodiesterase inhibitor completed Phase III clinical trial for the treatment of erectile dysfunction.
The company also develops VV116, a RNA-dependent RNA polymerase inhibitor completed a Phase II clinical trial for the treatment of respiratory syncytial virus infection, as well as COVID-19 infections; TPN102, a novel antiepileptic drug, which is in Phase I clinical trial for the treatment of epilepsy; VV119, a multi-target serotonin-dopamine activity modulator, which is in Phase I clinical trial for the treatment of psychiatric disorders and schizophrenia; VV261, a novel nucleoside prodrug, which is in Phase I clinical trial for chikungunya, coronaviruses, influenza, and arena virus.
In addition, it develops VV913, a novel investigational drug candidate for premature ejaculation; VV147 for the treatment of major depressive disorder; and VV207 for the treatment of adenovirus infection.
The company was incorporated in 2013 and is headquartered in Suzhou, China.
| Country | China |
| Founded | 2013 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| CEO | Guanghui Tian |
Contact Details
Address: Building A Suzhou China | |
| Phone | 86 512 6289 8837 |
| Website | vigonvita.cn |
Stock Details
| Ticker Symbol | 2630 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000076N3 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Guanghui Tian | Co-Founder, Executive Chairman, Chief Executive Officer and GM |
| Dr. Tianwen Hu | Deputy GM and Executive Director |
| Jingshan Shen | Founder |
| Zheng Yao | Financial Controller |
| Wing Sze Au | Joint Company Secretary |
| Ting Guo | Secretary of the Board and Joint Company Secretary |
| Dr. Zhiqiang Wang | Deputy General Manager |
| Qing Jin | Deputy Manager |